Use of antibodies or neutralizing molecules against TSLP, OX40L and CD177, as a treatment to ameliorate the disease in patients infected with human Metapneumovirus
Más información
Idioma: | TSLP; OX40L; CD177; HUMAN METAPNEUMOVIRUS |
DOI: |
PCT/IB2016/052180: W 2016/6927 |